Fiona Havers Selected Research

Fiona Havers Research Topics

8	Human Influenza (Influenza) 10/2019 - 07/2014
3	Whooping Cough (Pertussis) 01/2020 - 09/2018
2	Infections 09/2014 - 07/2014
1	Tetanus 01/2020
1	Diphtheria 01/2020
1	Cognitive Dysfunction 01/2018
1	Pneumonia (Pneumonitis) 01/2016
1	Disease Progression 07/2014
1	Nervous System Diseases (Neurological Disorders) 07/2014
1	HIV Infections (HIV Infection) 05/2004
1	Hyperinsulinism (Hyperinsulinemia) 05/2004
1	Insulin Resistance 05/2004
1	Lipodystrophy 05/2004

5	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2019 - 09/2014
5	VaccinesIBA 10/2019 - 07/2014
3	Antiviral Agents (Antivirals)IBA 06/2015 - 07/2014
2	AntibodiesIBA 01/2020 - 01/2017
2	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 10/2019 - 09/2018
2	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 10/2019 - 09/2018
1	Immunoglobulin G (IgG)IBA 01/2020
1	Pertussis VaccineIBA 10/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2014
1	ORALIT (ORS)IBA 09/2014
1	25-hydroxyvitamin DIBA 07/2014
1	PPAR-gamma AgonistsIBA 05/2004
1	Rosiglitazone (Avandia)FDA Link 05/2004
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 05/2004
1	PPAR gammaIBA 05/2004
1	LipidsIBA 05/2004
1	Glucose (Dextrose)FDA LinkGeneric 05/2004
1	AdiponectinIBA 05/2004
1	Nonesterified Fatty Acids (NEFA)IBA 05/2004

2	Therapeutics 09/2014 - 07/2014
1	Length of Stay 01/2016
1	Ambulatory Care (Outpatient Care) 09/2014